跳至主要内容
临床试验/ACTRN12610001020077
ACTRN12610001020077已完成2 期

In patients with achilles tendinopathy what is the short-term efficacy of adding autologous blood injection to conservative treatment compared with that of conservative treatment alone?

Jake Pearson0 个研究点目标入组 40 人开始时间: 2010年11月22日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
16 Years 至 o limit(—)
性别
All

入选标准

  • Diagnosis of mid achilles tendinopathy (activity-related pain of gradual or semi-acute onset, post-inactivity stiffness, and tenderness, swelling and nodularity localised to the mid-tendon) with duration of symptoms of at least three months.

排除标准

  • Diagnostic uncertainty or concurrent presence of insertional pathology,
  • Anticoagulant therapy,
  • Systemic disease that may contribute to pathology,
  • Elite level sportsperson, or
  • Having received any injection therapy for the tendon within the last three months.

研究者

发起方
Jake Pearson

相似试验

Autologous Blood Injection for Treatment of Achilles... | 临床试验